4.5 Article

The burden of influenza A and B in Mexico from the year 2010 to 2013: An observational, retrospective, database study, on records from the Directorate General of Epidemiology database

Journal

HUMAN VACCINES & IMMUNOTHERAPEUTICS
Volume 14, Issue 8, Pages 1890-1898

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2018.1456281

Keywords

Epidemiology; Influenza A; Influenza B; Influenza vaccine; Mexico; Surveillance

Funding

  1. GlaxoSmithKline GSK Biologicals SA [201075]
  2. GSK Biologicals SA

Ask authors/readers for more resources

Despite vaccination programs, influenza still represents a significant disease burden in Mexico. We conducted an observational, retrospective analysis to better understand the epidemiological situation of the influenza virus in Mexico. Analysis of the seasonal patterns of influenza A and B were based on the Directorate General of Epidemiology dataset of influenza-like illness(ILI), and severe acute respiratory infection(SARI) that were recorded between January 2010 and December 2013. Our objectives were 1) to describe influenza A and B activity, by age group, and subtype and, 2) to analyze the number of laboratory-confirmed cases presenting with ILI by influenza type, the regional distribution of influenza, and its clinical features. Three periods of influenza activity were captured: August 2010-January 2011, December 2011-March 2012, and October 2012-March 2013. Cases were reported throughout Mexico, with 50.3% (n = 10,320) of cases found in 18-49 year olds. Over the entire capture period, a total of 76,085 ILI/SARI episodes had swab samples analyzed for influenza, 27% were positive. During the same period, influenza A cases were higher in the 18-49 years old, and influenza B cases in both 5-17 and 18-49 age groups. Peak activity occurred in January 2012 (n = 4,159) and December 2012 (n = 348) for influenza A and B respectively. This analysis confirms that influenza is an important respiratory pathogen for children and adults in Mexico despite vaccination recommendations. School-age children and adolescents were more prone to influenza B infection; while younger adults were susceptible to both influenza A and B viruses. Over the seasons, influenza A and B co-circulated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

Eduardo Lopez-Medina, Shibadas Biswal, Xavier Saez-Llorens, Charissa Borja-Tabora, Lulu Bravo, Chukiat Sirivichayakul, Luis Martinez Vargas, Maria Theresa Alera, Hector Velasquez, Humberto Reynales, Luis Rivera, Veerachai Watanaveeradej, Edith Johana Rodriguez-Arenales, Delia Yu, Felix Espinoza, Reynaldo Dietze, Lak Kumar Fernando, Pujitha Wickramasinghe, Edson Duarte Moreira, Asvini D. Fernando, Dulanie Gunasekera, Kleber Luz, Rivaldo Venancio da Cunha, Vianney Tricou, Martina Rauscher, Mengya Liu, Inge LeFevre, Derek Wallace, Pope Kosalaraksa, Astrid Borkowski

Summary: Takeda's tetravalent dengue vaccine (TAK-003) demonstrated high overall efficacy in a 2-year vaccine study, with some decline in efficacy observed in the second year. However, efficacy varied across different age groups, indicating the need for further monitoring of the vaccine's long-term effects.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Clinical Neurology

Stroke Among SARS-CoV-2 Vaccine Recipients in Mexico A Nationwide Descriptive Study

Diego Lopez-Mena, Miguel Garcia-Grimshaw, Sergio Saldivar-Davila, Laura Elena Hernandez-Vanegas, Maria del Mar Saniger-Alba, Alonso Gutierrez-Romero, Roger Carrillo-Mezo, Hector Eduardo Valdez-Ruvalcaba, Vanessa Cano-Nigenda, Fernando Daniel Flores-Silva, Carlos Cantu-Brito, Ana Maria Santibanez-Copado, Jose-Luis Diaz-Ortega, Santa Elizabeth Ceballos-Liceaga, Luis Manuel Murillo-Bonilla, Ana Isabel Sepulveda-Nunez, Veronica Garcia-Talavera, Eduardo Gonzalez-Guerra, Ricardo Cortes-Alcala, Hugo Lopez-Gatell, Guillermo Carbajal-Sandoval, Gustavo Reyes-Teran, Sergio Ivan Valdes-Ferrer, Antonio Arauz

Summary: This study reports on the incidence of stroke among recipients of different SARS-CoV-2 vaccines in Mexico. The study found that stroke is an exceedingly rare adverse event following immunization, and most patients had preexisting risk factors for stroke.

NEUROLOGY (2022)

Article Virology

Dominance of Three Sublineages of the SARS-CoV-2 Delta Variant in Mexico

Blanca Taboada, Selene Zarate, Rodrigo Garcia-Lopez, Jose Esteban Munoz-Medina, Alejandro Sanchez-Flores, Alfredo Herrera-Estrella, Celia Boukadida, Bruno Gomez-Gil, Nelly Selem Mojica, Mauricio Rosales-Rivera, Angel Gustavo Salas-Lais, Rosa Maria Gutierrez-Rios, Antonio Loza, Xaira Rivera-Gutierrez, Joel Armando Vazquez-Perez, Margarita Matias-Florentino, Marissa Perez-Garcia, Santiago Avila-Rios, Juan Manuel Hurtado, Carla Ivon Herrera-Najera, Jose de Jesus Nunez-Contreras, Brenda Sarquiz-Martinez, Victor Eduardo Garcia-Arias, Maria Guadalupe Santiago-Mauricio, Bernardo Martinez-Miguel, Julissa Enciso-Ibarra, Cristobal Chaidez-Quiroz, Pavel Isa, Rosa Maria Wong-Chew, Maria-Eugenia Jimenez-Corona, Susana Lopez, Carlos F. Arias

Summary: In this study, the sequences of SARS-CoV-2 Delta variant isolates in Mexico were analyzed. The dominant sublineages were AY.20, AY.26, and AY.100, which may have originated in Mexico. These sublineages showed different geographical distributions in the country. The study highlights the importance of genomic surveillance for timely identification of emerging variants.

VIRUSES-BASEL (2022)

Article Microbiology

The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico

Selene Zarate, Blanca Taboada, Jose Esteban Munoz-Medina, Pavel Isa, Alejandro Sanchez-Flores, Celia Boukadida, Alfredo Herrera-Estrella, Nelly Selem Mojica, Mauricio Rosales-Rivera, Bruno Gomez-Gil, Angel Gustavo Salas-Lais, Clara Esperanza Santacruz-Tinoco, Hector Montoya-Fuentes, Julio Elias Alvarado-Yaah, Gloria Maria Molina-Salinas, Gloria Elena Espinoza-Ayala, Jose Antonio Enciso-Moreno, Rosa Maria Gutierrez-Rios, Antonio Loza, Joaquin Moreno-Contreras, Rodrigo Garcia-Lopez, Xaira Rivera-Gutierrez, Andreu Comas-Garcia, Rosa Maria Wong-Chew, Maria-Eugenia Jimenez-Corona, Rosa Maria del Angel, Joel Armando Vazquez-Perez, Margarita Matias-Florentino, Marissa Perez-Garcia, Santiago Avila-Rios, Hugo G. Castelan-Sanchez, Luis Delaye, Leon P. Martinez-Castilla, Marina Escalera-Zamudio, Susana Lopez, Carlos F. Arias

Summary: The B.1.1.7 (Alpha) lineage of SARS-CoV-2 emerged and rapidly increased worldwide, but did not become the dominant lineage in most of Mexico. The states at the Mexico-U.S. border had the highest prevalence of B.1.1.7 and showed the highest lineage diversity, suggesting possible introductions from the United States. Community transmission of B.1.1.7 occurred in Mexico, as evidenced by localized distribution and specific mutations.

MICROBIOLOGY SPECTRUM (2022)

Article Clinical Neurology

Incidence of Guillain-Barre syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines

Miguel Garcia-Grimshaw, Javier Andres Galnares-Olalde, Omar Yaxmehen Bello-Chavolla, Anaclara Michel-Chavez, Arturo Cadena-Fernandez, Maria Eugenia Briseno-Godinez, Neftali Eduardo Antonio-Villa, Isaac Nunez, Alonso Gutierrez-Romero, Laura Hernandez-Vanegas, Maria del Mar Saniger-Alba, Roger Carrillo-Mezo, Santa Elizabeth Ceballos-Liceaga, Guillermo Carbajal-Sandoval, Fernando Daniel Flores-Silva, Jose Luis Diaz-Ortega, Ricardo Cortes-Alcala, Jose Rogelio Perez-Padilla, Hugo Lopez-Gatell, Erwin Chiquete, Gustavo Reyes-Teran, Antonio Arauz, Sergio Ivan Valdes-Ferrer

Summary: This study in Mexico found that the incidence of Guillain-Barre syndrome (GBS) as an adverse event following immunization (AEFI) against SARS-CoV-2 is extremely low. The vaccines provide more protection than the risk of developing GBS.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Immunology

Clinical and Virological Features of Patients Hospitalized with Different Types of COVID-19 Vaccination in Mexico City

Alejandra Hernandez-Teran, Pamela Garciadiego-Fossas, Marco Villanueva-Reza, Celia Boukadida, Blanca Taboada, Eduardo Porras, Victor Ahumada-Topete, Kathia Elizabeth Tapia-Diaz, Margarita Matias-Florentino, Marissa Perez-Garcia, Santiago Avila-Rios, Fidencio Mejia-Nepomuceno, Ricardo Serna-Munoz, Fortunato Juarez-Hernandez, Maria Eugenia Jimenez-Corona, Eduardo Becerril-Vargas, Omar Barreto, Jose Arturo Martinez-Orozco, Rogelio Perez-Padilla, Carlos F. Arias, Joel Armando Vazquez-Perez

Summary: This study compares the clinical presentations and outcomes of COVID-19 patients who were vaccinated and those who were not. The results suggest that vaccination is essential in reducing in-hospital mortality, especially for individuals aged 61 and above.

VACCINES (2022)

Article Public, Environmental & Occupational Health

Knowledge, attitudes, perceptions, and COVID-19 hesitancy in a large public university in Mexico city during the early vaccination rollout

Norma Mongua-Rodriguez, Mauricio Rodriguez-Alvarez, Daniela De-la-Rosa-Zamboni, Maria Eugenia Jimenez-Corona, Martha Lucia Castaneda-Cediel, Guadalupe Miranda-Novales, Gustavo Cruz-Pacheco, Elizabeth Ferreira-Guerrero, Leticia Ferreyra-Reyes, Guadalupe Delgado-Sanchez, Maribel Martinez-Hernandez, Arturo Cruz-Salgado, Rogelio Perez-Padilla, Samuel Ponce-de-Leon, Lourdes Garcia-Garcia

Summary: The prevalence of COVID-19 vaccine hesitancy among academics, students, and administrative personnel of a public university in Mexico City is low. Factors associated with hesitancy include fear of adverse effects, distrust of physician's recommendations, lack of knowledge regarding handwashing, age younger than 40 years, refusal to use face masks, and not having received influenza vaccination during the two previous seasons.

BMC PUBLIC HEALTH (2022)

Article Immunology

Nosocomial RSV-related In-hospital Mortality in Children <5 Years: A Global Case Series

Yvette N. N. Lowensteyn, Joukje E. E. Willemsen, Natalie I. I. Mazur, Nienke M. M. Scheltema, Nynke C. J. van Haastregt, Amber A. A. ten Buuren, Ichelle van Roessel, Dunja Scheepmaker, Harish Nair, Peter M. M. van de Ven, Louis J. J. Bont

Summary: This study provides the first global case series of children dying with nosocomial RSV infection. Infant-targeted immunization strategies in the future could prevent the majority of nosocomial RSV-related deaths. Although nosocomial RSV deaths are expected to occur at highest rates in low- and lower-middle-income countries (LMICs), the reported number of these deaths was low in these countries. Hospital-based surveillance is needed to capture the full burden of nosocomial RSV mortality in LMICs.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2023)

Article Public, Environmental & Occupational Health

Ten-year hospitalization trends in Mexico: Examining the profile of national and transient and migrants

Rene Leyva-Flores, Belkis Aracena-Genao, Nirma D. Bustamante, Ietza Bojorquez, Ricardo Cortes-Alcala, Diana Gomez-Lopez, Miguel Adonai Perez-Sastre

Summary: This study aims to examine the factors and trends of Mexican and foreign resident hospitalizations in Mexican public hospitals from 2010 to 2020. The study found that the hospitalization rate of foreign residents is increasing, while the rate for Mexican residents remains stable. Obstetric causes were the most common reason for hospitalization among foreign residents, while trauma was the second leading cause among Mexican residents.

FRONTIERS IN PUBLIC HEALTH (2023)

Article Infectious Diseases

Effectiveness of a nationwide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis of national surveillance data

Omar Yaxmehen Bello-Chavolla, Neftali Eduardo Antonio-Villa, Sergio Ivan Valdes-Ferrer, Carlos A. Fermin-Martinez, Luisa Fernandez-Chirino, Arsenio Vargas-Vazquez, Daniel Ramirez-Garcia, Javier Mancilla-Galindo, Ashuin Kammar-Garcia, Jose Alberto Avila-Funes, Clemente Humberto Zuniga-Gil, Miguel Garcia-Grimshaw, Santa Elizabeth Ceballos-Liceaga, Guillermo Carbajal-Sandoval, Jose Antonio Montes-Gonzalez, Christian Arturo Zaragoza-Jimenez, Gabriel Garcia-Rodriguez, Ricardo Cortes-Alcala, Gustavo Reyes-Teran, Hugo Lopez-Gatell, Luis Miguel Gutierrez-Robledo

Summary: This study reports the vaccine effectiveness (VE) of the nationally available COVID-19 vaccines in Mexico. The VE against SARS-CoV-2 infection was highest for mRNA-12732 and Ad26.COV2.S vaccines, for COVID-19 hospitalization BNT162b2 and Gam-COVID-Vac vaccines, and for mortality BNT162b2 and mRNA-12732 vaccines.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Multidisciplinary Sciences

A characterization of cross-border use of health services in a transborder population at the Mexico-Guatemala border, September-November 2021

Cesar Rodriguez-Chavez, Silvana Larrea-Schiavon, Rene Leyva-Flores, Nirma D. D. Bustamante, Marcel Arevalo, Ricardo Cortes-Alcala, Georgina Rodriguez, Rebecca Merrill, Dianne Escotto, Ietza Bojorquez

Summary: Cross-border use of health services in the Mexico-Guatemala border region is associated with transborder work, highlighting the importance of considering the health needs of migrant workers and developing strategies to facilitate their access to healthcare.

PLOS ONE (2023)

Article Public, Environmental & Occupational Health

Prevalence of antibodies and SARS-CoV-2 vaccination in Mexico 2022

Martha Carnalla, Ana Basto-Abreu, Dalia Stern, M. Arantxa Colchero, Sergio Bautista-Arredondo, Celia M. Alpuche-Aranda, Jesus Martinez-Barnetche, Martin Romero-Martinez, Ricardo Cortes-Alcala, Irma Lopez-Martinez, Rodrigo Aparicio-Antonio, Tonatiuh Barrientos-Gutierrez

Summary: This study describes the prevalence of antibodies against SARS-CoV-2, vaccination rates, and barriers to and rejection of Covid-19 vaccination in the Mexican population. The results show high levels of antibodies from both natural infection and vaccination. Variations in vaccination refusal and barriers among different age groups and regions highlight the need for targeted vaccination efforts.

SALUD PUBLICA DE MEXICO (2023)

Article Health Care Sciences & Services

Epidemiological and clinical characteristics of patients with human monkeypox infection in Mexico: a nationwide observational study

Isaac Nunez, Miguel Garcia-Grimshaw, Santa E. Ceballos-Liceaga, Carla Toledo-Salinas, Guillermo Carbajal-Sandoval, Luisa Sosa-Laso, Gabriel Garcia-Rodriguez, Ricardo Cortes-Alcala, Alethse de la Torre, Sergio Fragoso-Saavedra, Alejandro Quintero-Villegas, Hugo Lopez-Gatell, Gustavo Reyes-Teran, Sergio Ivan Valdes-Ferrer

Summary: The 2022 monkeypox outbreak in Mexico is mainly driven by middle-aged men who have sex with men, many of whom are living with human immunodeficiency virus infection. Clinical features, such as a high proportion of anogenital lesions and proctitis, suggest that sexual contact is a pivotal transmission mechanism in this outbreak.

LANCET REGIONAL HEALTH-AMERICAS (2023)

Article Health Care Sciences & Services

Leading causes of excess mortality in Mexico during the COVID-19 pandemic 2020-2021: A death certificates study in a middle-income country

Lina Sofia Palacio-Mejia, Juan Eugenio Hernandez-Avila, Mauricio Hernandez-Avila, Dwight Dyer-Leal, Arturo Barranco, Amado D. Quezada-Sanchez, Mariana Alvarez-Aceves, Ricardo Cortes-Alcala, Jorge Leonel Fernandez-Wheatley, Iliana Ordonez-Hernandez, Edgar Vielma-Orozco, Maria de la Cruz Muradas-Troitino, Omar Muro-Orozco, Enrique Navarro-Luevano, Kathia Rodriguez-Gonzalez, Jean Marc Gabastou, Ruy Lopez-Ridaura, Hugo Lopez-Gatell

Summary: COVID-19 became the leading cause of death in Mexico in 2020-2021, and the increase in other causes of death may be attributed to changes in healthcare utilization patterns caused by hospital conversion or public fear of using them. Cause-misclassification cannot be ruled out.

LANCET REGIONAL HEALTH-AMERICAS (2022)

Article Infectious Diseases

Detection of Mansonella ozzardi in peripheral blood in two malaria-endemic areas in Panama

Jose Antonio Suarez, Dianik Moreno, Juan Miguel Pascale, Lorena Romero, Nestor Sosa, Fergie Ruiz, Rodrigo DeAntonio, Alberto Cumbrera, Carlos Franco-Paredes, Jose Anel Gonzalez

Summary: This study conducted a cross-sectional assessment of peripheral blood samples from individuals across Panama and confirmed the presence of Mansonella ozzardi infection in Panama, with the first report of its presence in the Eastern region of the country.

THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE (2022)

No Data Available